A 2018 phase I study published in the Journal of Clinical Oncology by Thomas et al. evaluated the ATR inhibitor M6620 in combination with topotecan in patients with advanced solid tumors.

Authors

• Person: Not available Organization: Nature
  Perspectives on cancer therapy—synthetic lethal precision medicine ...

Sources

• Perspectives on cancer therapy—synthetic lethal precision medicine ... www.nature.com Nature via serper

Referenced by nodes (1)

• ATR inhibitors concept